Monopar Therapeutics
Pharmaceutical company · Wilmette, Illinois, United States · Nasdaq: MNPR
Monopar Therapeutics is a pharmaceutical company headquartered in Wilmette, Illinois, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker MNPR. It has reported private securities offerings to the US SEC, most recently $2.1 million sold in a notice filed in 2015.
Monopar Therapeutics at a glance
What does Monopar Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $2.1 million sold (2015).
Frequently asked questions about Monopar Therapeutics
Where is Monopar Therapeutics headquartered?
Monopar Therapeutics is headquartered in Wilmette, Illinois, United States.
What does Monopar Therapeutics do?
Monopar Therapeutics is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Monopar Therapeutics a public company?
Yes. Monopar Therapeutics trades on Nasdaq under the ticker MNPR.
When was Monopar Therapeutics founded?
The earliest incorporation on record for Monopar Therapeutics is in 2015, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences